310 related articles for article (PubMed ID: 37121469)
21. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Marik PE; Varon J
Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
[TBL] [Abstract][Full Text] [Related]
22. The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies.
Bae JH; Lim H; Lim S
Adv Nutr; 2023 Jul; 14(4):612-628. PubMed ID: 37031750
[TBL] [Abstract][Full Text] [Related]
23. Association of Polyunsaturated Fatty Acid Intake on Inflammatory Gene Expression and Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Ghasemi Darestani N; Bahrami A; Mozafarian MR; Esmalian Afyouni N; Akhavanfar R; Abouali R; Moradian A; Lorase S
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364885
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
25. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38869144
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
27. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
[TBL] [Abstract][Full Text] [Related]
28. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
Siscovick DS; Barringer TA; Fretts AM; Wu JH; Lichtenstein AH; Costello RB; Kris-Etherton PM; Jacobson TA; Engler MB; Alger HM; Appel LJ; Mozaffarian D;
Circulation; 2017 Apr; 135(15):e867-e884. PubMed ID: 28289069
[TBL] [Abstract][Full Text] [Related]
29. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
[TBL] [Abstract][Full Text] [Related]
30. Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease-Possible Causes and Future Considerations.
Michaeloudes C; Christodoulides S; Christodoulou P; Kyriakou TC; Patrikios I; Stephanou A
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004225
[TBL] [Abstract][Full Text] [Related]
31. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.
O'Mahoney LL; Matu J; Price OJ; Birch KM; Ajjan RA; Farrar D; Tapp R; West DJ; Deighton K; Campbell MD
Cardiovasc Diabetol; 2018 Jul; 17(1):98. PubMed ID: 29981570
[TBL] [Abstract][Full Text] [Related]
33. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Aung T; Halsey J; Kromhout D; Gerstein HC; Marchioli R; Tavazzi L; Geleijnse JM; Rauch B; Ness A; Galan P; Chew EY; Bosch J; Collins R; Lewington S; Armitage J; Clarke R;
JAMA Cardiol; 2018 Mar; 3(3):225-234. PubMed ID: 29387889
[TBL] [Abstract][Full Text] [Related]
34. Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
Luo S; Hou H; Wang Y; Li Y; Zhang L; Zhang H; Jin Q; Wu G; Wang X
Food Funct; 2024 Feb; 15(3):1208-1222. PubMed ID: 38224465
[No Abstract] [Full Text] [Related]
35. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
Kelaiditis CF; Gibson EL; Dyall SC
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 Fatty Acids and Cardiovascular Disease: A Narrative Review for Pharmacists.
Patel D; Busch R
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):524-532. PubMed ID: 34191622
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
[No Abstract] [Full Text] [Related]
38. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W
Eur J Clin Nutr; 2018 Jun; 72(6):805-817. PubMed ID: 29284786
[TBL] [Abstract][Full Text] [Related]
39. The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials.
AbuMweis S; Abu Omran D; Al-Shami I; Jew S
Complement Ther Med; 2021 Mar; 57():102662. PubMed ID: 33418065
[TBL] [Abstract][Full Text] [Related]
40. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
